Glucotrack GCTK 深 沪
已收盘 09-25 16:00:00 美东时间
1.82
-0.760
-29.46%
华盛通- 最 高2.36
- 今 开2.31
- 成交量 202.34万股
- 最 低 1.77
- 昨 收 2.58
- 总市值 145.31万
- 52周最高 136.29
- 市盈率 静 --
- 换手率 253.43%
- 52周最低 1.77
- 委 比 -58.42%
- 总股本 79.84万
- 历史最高 436500.00
- 量 比 0.13
- 振 幅 22.87%
- 历史最低 1.77
- 每 手 1
- 风险率 36.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多GlucoTrack Announces Debt-Reducing Public Equity Offering
GlucoTrack ( ($GCTK) ) has provided an update. On September 24, 2026, Glucotrac...
09-25 06:16
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours
Glucotrack, Inc. (NASDAQ:GCTK) shares are trending on Wednesday night. Shares of the New Jersey-based medical device and biotechnology company surged 80.30% to $3.66 in after-hours trading on Wednesday following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fe...
09-24 11:14
GlucoTrack and Lōkahi Outline Post-Merger Strategic Focus
GlucoTrack ( ($GCTK) ) has provided an update. On September 23, 2026, Lōkahi Th...
09-23 21:48
Lōkahi Therapeutics And Glucotrack Issue Update On LT-100 Program And ai² Asset Monetization Strategy
Lōkahi Therapeutics™ today issued a strategic corporate update highlighting progress in its LT-100 development program, expansion of its ai² platform, and priorities for advancing and monetizing differentiated therapeutic assets. A Clear View of Who We Are A Message From Our CEO, Erik Emerson Good m...
09-23 21:07
GlucoTrack Director Resigns Amid Merger Conflict Concerns
An update from GlucoTrack ( ($GCTK) ) is now available. On September 14, 2026, ...
09-19 05:24
GlucoTrack Amends Warrant Terms Pending Shareholder Approval
GlucoTrack ( ($GCTK) ) has issued an update. On August 4, 2026, GlucoTrack ente...
09-15 05:55
Glucotrack shares are trading lower after the company announced an $11.5 million financing.
Glucotrack shares are trading lower after the company announced an $11.5 million financing.
09-11 22:05
Glucotrack announces $11.5M financing
Glucotrack (GCTK) announced on Friday it had entered into agreements for approximately $11.5M in convertible notes, including $4.5M in new cash investment. The financing also includes $4.5M of existin...
09-11 20:13
Glucotrack Secures $11.5M Convertible Note Financing
Glucotrack, Inc. (NASDAQ:GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including approximately $4.5 million of new cash investment and approximately $4.5 million of existing notes b...
09-11 20:01
GlucoTrack Settles Disputed Debt with Convertible Note
GlucoTrack ( ($GCTK) ) has issued an announcement. On September 4, 2026, Glucot...
09-10 06:24
